New Zealand Pharmaceuticals & Healthcare Report Q2 2018

New Zealand Pharmaceuticals & Healthcare Report Q2 2018

BMI View:

New Zealand's pharmaceutical and healthcare markets continue to draw interest from innovative drugmakers, givenfactors such as the high level of care and also of chronic disease burden. However, the operating environment will remainchallenging due to the restrictive operating environment, in particular the focus on cost containment.

BMI Industry View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Region Characterised By A Mix Of Risks And Rewards
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Douglas Pharmaceuticals
New Zealand Pharmaceuticals
Pfizer New Zealand
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook